Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The specific skin disease variant p.(Arg2000Trp) in plectin can cause a wide range of symptoms, which should be considered when diagnosing patients.

Tyrosinase and gp100 proteins can help diagnose and treat melanoma.

GLP-1 therapies can cause hair loss, but hair often regrows after stopping or reducing the drug.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

GLP-1RA medications may increase the risk of hair loss, especially in non-diabetic people.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

A boy with Oculodentodigital syndrome had a unique GJA1 gene mutation causing his symptoms.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

The hydrogel scaffold improved skin flap healing and reduced inflammation.

Following recommended practices can make gluteal fat transplantation safer.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

GPC1 is important for blood vessel growth in hair follicles and could help treat hair loss.

Researchers created a new mouse model for studying scleroderma.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

A specific gene region can control targeted and responsive gene expression in mice, useful for skin disorder treatments.

The hair disorder was caused by abnormal protein formation, making hair easily damaged.

Kaposi's sarcoma lesions might originate from benign tissue changes.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

GLABRA 2 controls ethylene production to help root hair growth during nutrient deficiency.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

The protein called small nuclear ribonucleoprotein polypeptide E is identified as a cause of a type of hair loss without other symptoms.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

Deleting a specific protein in skin cells disrupts normal hair growth and development.